Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Monday lets watch for some fantastic news without dilution. Fantastic which will help the share price to recover. Yes news that is not accomplish by dilution. The Walmart debut for Rainbow Rangers and accessories. Bicycles and helments.
To those whom thought Genius Brands International Inc (GNUS) was a diamond in the rug, what do they think of the stock now after faling more than $11.73 down to $1.45 like a brick from the sky.
Every one don't tune in or read instagram imo Andy Heyward and Genius Brands International inc is trying to destroy the shareholders to force a r/s and start over with a fresh new low out standing share count, and a new list of press releases to boost the share price up so their new investors can dump the new converted authorized shares they've received very cheap from Andy and Genius Brands international.
Genius Brands International sell shares for huge salaries.
Too much dilution is what is killing the share price and us shareholders. What we need is for Genius Brands International inc is to stop keeping the share price so low. for the share price to be under $2 a share is insane on Andy Heyward part, because he is the CEO of this company and he claim he knows what he is doing but, I don't think so.
The share price only move up to 2.21 after Genius Brands update today. We're in trouble unless that iOS APP to be released this month before August can get the shareholders out of the RED zone. Geeze.
How many shares does these jerks have left to dump so this stock can go back up and let me exit with some of my hard earned money.
Pain and mad like hell. At this point I really hate this stock GNUS and Genius Brands international. I'm getting closer of hating the products The dilution never seem to stop. Have loss more than 1/3 of my investment. Plus Andy the CEO don't give a damn about its Genius Brand's shareholders
What a piece of crap this kiddie company has turn out to be and many of us adults fell for the company's baited traps, lost so much money. Genius Brands international inc you crooks should be a shame of yourselves.
Could we please get back to $5 dollars so Genius Brands International Inc can attract more mutual funds investors with deep pockets, Andy.
Wake up Genius Brands International and get the LLama and Rainbow Rangers stock GNUS moving forward 'UP'. The Shares Holders is counting on you and the executive team. No reasons for the share price to be this low. Many paid over $5 to $10 a share, thinking Genius Brands had something worth investing. Now many has doubts about Genius Brands after experiencing the huge drop in Genius Brands International share price. this is becoming very painful watching your investment one thought were a great investment sink lower and lower each day.
We need some fire power, where are the Rainbow Rangers...LOL
Genius brands soared to $11.73 last month. Looking for it to soar to at least 1/3 the amount tomorrow with the great news we received yesterday.
I'm looking for the share price to go back to $4 this month.
Lets double that today.
Last week PR IMO the company Evoke Pharma were letting its shareholders know that the ER is going to be great. Evoke and Eversana is now doing pre commercialization for Gimoti Nasal Spray. The company and its partner Eversana is launching Gimoti in the 4th quarter which starts in September. This news should give the share price a great spike before Earnings next month.
We are going up much higher this month now that the Markets and shareholders know Evoke Pharma is planning on bring Gimoti nasal spray drug to treat Diabetic Gastroparesis to the commercial prescription sale Market. Up to $4 billion dollar annual prescription in sales to treat the symptoms caused by Diabetic Gastroparesis, that is triggered by Diabetes.
We will get our huge run without doing a thing but being in before share price appear one early morning at the top, and you shorts and Longs know what I mean by at the top. Will give you a hint, it mostly happen around 4 am and 6 am on a weekday morning.
I'm waiting for that Beautiful Morning.
You guys and myself need to give Evoke Pharma Inc a little more time to get something together. It has only been a week ago since we received the press release the FDA approve NDA for Gimoti (metoclopramide) Nasal Spray to treat Diabetic Gastroparesis. The Board members and CEO is not sitting around and doing nothing with an approve high quality advance Diabetic Gastroparesis therapeutic treatment the first of its kind in a nasal spray worth Billions in prescription sales. Last Friday June 19, 2020 the FDA approve EVoke's Pharma inc Drug Gimoti nasal spray for commercial prescription use in a $4 billion prescription sales market with only 1 real competitor treating Gastroparesis disease with a pill form of metoclopramide. No one else can't sale the Nasal Spray form of Metoclopramide it is patent until 2030. So Evoke alone can sale nasally use form of metoclopramide.
Whether Evoke Pharma sale the company or Let Eversana Science Manufacture Gimoti Nasal Spray, commercialize, handle distribution, handle sales using their own professional sales team, and patients insurance and re-imbursements. this will be the duties of Eversana. In return Everana Science will receive 20% of Gimoti (metoclopramide) nasal spray profits, and Evoke Pharma inc will get 80% of Gimoti (metoclopramide) nasal spray profits. As of last week Friday Evoke Pharma is eligible for a $5 million dollar line of credit from Eversana.
Evoke Pharma had in the PR Gimoti will be market in the 4th quarter this year. To some that might seem like a long time 3 more full months before 4th quarter, but it is not. Evoke and Eversana need time to do all the duties mention in this second paragraph above. I'm just going to be adding while the share price is still more affordable to buy for my money a few shares at a time each pay period or from sells of other stocks.
Good Luck to all us Evoke shareholders soon to be millionaires.
EVOK went up to 3.99 on today's pop. The company is answering emails, which is great for some type of communication. Glad shareholders are sharing emails with others on different boards. We all need this communication. Would like to had what the company stated in the email in a press release to come some of the anxiety shareholders are having due to share price drops in the last few day. I 'am glad it is back up some today.
Oh shut the helll up shorty !!
Meds that help treat illness cause by Diabetes such as Diabetic Gastroparesis disease that will help patients to have a better quality of health and life are prescribe over the other medical drugs in the medical field that is less therapeutic to treat their illness cause by diabetes. Gimoti will be a much better sorb after treatment for Diabetic Gastroparesis disease by Patients and their Physicians.
Whether or not Evoke Pharma Inc go ahead and market this drug or sell the company it will be a great therapeutic drug to treat Diabetic Gastroparesis which will grab a huge portion of the Gastroparesis medical prescription sales. I'm willing to hold either way, hold for a buyout or for Evoke to have Gimoti manufacture and sold for them.
Would like to here Evoke Pharma inc issue a shareholders conference call to let shareholders know what are their plans now since Gimoti nasal spray is FDA approve for commercial sales.
Right, Weak hands are out, strong hands are holding stronger, because we didn't fall for the stupid shorts and bears scare tactics and false information, plus old old news. Shorts had fun with peeps whom don't do their own research, and for that, they rely on all the false information the shorts and bears feed them.
Here are some facts go to the company website and read for yourself.
Evoke Pharma inc Partnership with Eversana Science to handle all of Gimoti manufacturing, distribution, Commercialization, sales teams. In return Eversana get 20% of the profits generated by Gimoti and in return Evoke Pharma inc get a $5 million equity line of credit from Eversana after FDA approval of Gimoti, and Evoke Pharma inc gets 80% of Gimoti profits.
The contract deal can be cancel by both parties. A manufacture is part of a FDA approval for a drug. Evoke Pharma inc has already set the process up for a buyout and has $4.7 million in cash as of May 31 and a equity credit line for $5 million, Plus company is debt free. Great recipe set up for a buyout.
company only had 5 employees, so what in the devil they need with all that cash when they're not doing any manufacturing, distribution, commercialization, or hiring a sales team for Gimoti, all this is handle by Eversana, not Evoke Pharma Inc. They will just be getting paid like the shareholders.
Evoke Pharma inc and the shareholders is the owners of a $4 billion dollar annual prescription drug market, with only one oral pill on the market that doesn't work very well to treat Gastroparesis disease, because like food and oral medication it is delay in the stomach because of gastric delay emptying of the stomach contents.
Gimoti nasal spray by pass the GI system and goes straight to the bloodstream which start to relief symptoms cause by Gastroparesis in minutes. Unlike the Pill form which takes hours and some times a day to work to relief symptoms, because of gastric delay empty of the stomach.
Evoke is expected to take a huge portion of the prescription market to treat Gastroparesis and Diabetic Gastroparesis disease in females. The company expect first year of sales up to 2/3 to treat the Diabetic Gastroparesis disease up to a $4 billion prescription market. Gimoti nasal spray the first of it kind to treat adult Females Diabetic Gastroparesis disease. Evoke expect millions of female worldwide to benefit from the use of Gimoti to treat their symptoms cause by diabetic gastroparesis disease.
Gimoti has its FDA approval for Gimoti Nasal Spray. The Bad Market today can't take that away. The stock may not have received its fair share price today for an important drug in demand treatment needed around the world, Gimoti Nasal Spray will get its fair share price. One way or the other. We own a very valuable treatment drug for Diabetic Gastroparesis disease that is in great demand. Gimoti the first of its kind to treat Diabetic Gastroparesis disease in 85% of adult females suffers with symptoms cause by the disease such as nausea, vomiting, Pain and Bloating.
Diabetic Gastroparesis is a disease which delay or slows the gastric emptying of the stomach contents after a meal and oral medication, which intern interferes with the glucose level in the blood. Gastroparesis disease is a $4 billion annual medical prescription to treat the disease and Gimoti Nasally form of metoclopramide is the first of its kind to treat diabetic gastroparesis in adult females.
Thank "aphib" I admire your honesty and positivity we all whom had held "EVOK" every since last year and some much longer is ready to reap the fruit of labor from EVOK. I myself is looking for a buyout and possible a bidding war between large Pharmaceutical companies and manufacturing companies such as J&J, Merck, and others. If we give it 3 years "EVOK" could be a stock worth over $100 a share, but I'll take the highest buyout or bid per share. Plus Evoke Pharma is DEBT FREE.
Looking for a Shareholders conference call with Evoke Pharma to let shareholders know what their plans are since Gimoti received a FDA approval for NDA Gimoti. This will be great news if the company could release a PR during Monday's pre market about for a shareholders conference call, time and date.
Well in the hell do you shorts keep printing these misleading information. The company is not in dangers of bankruptcy. Evoke Pharma Inc is debt free. as of May 31 they have $4.7 million in cash and a $5 million dollar equity line of credit with Eversana, which will be Evoke Manufacture for Gimoti, distribution, commercializing Gimoti, providing the professional sale team for Gimoti.
if your going to spread something spread the truth. I hate liars.
We would've received a bigger spike for Gimoti if peeps was not so afraid it might have been turn down for approval. I stuck it out, because the 3 things in the CRL mention about was easy to address and fix items. Plus when the FDA let Evoke Pharma know they accepted the Gimoti Brand name I had the feeling Gimoti is a Go !!
Monday would put a much brighter light on the share price, because many peeps had turned off their computers to start the weekend and didn't pay any attention to after hours. I've the feeling Evoke Pharma will be getting great buyout offers coming in pretty soon. This is a $2- $4 billion annual drug sales. The pill form of Metoclopramide is the only oral form on the market and it barely works. Plus in the Company's press release stated that Gimoti Nasal Spray will be the first drug to treat Diabetic Gastroparesis disease in women.
Gimoti is going to bring in the buyout offers. Hold on Shareholders we're about to get paid big time. Let the flippers have the chump change.
The only reason I still have close to the shares I've is because it made that big dip back to .80ish this year.
I've been here for 15 months and I've been thorough the CRL, the special "A" meeting with the FDA, the re-submitting of NDA for Gimoti Nasal Spray, the bull with the Bears, shorts, flipper, and the bull sh^tting fake Bulls. I'm now ready for June 19th to put all of this stuff behind me. Either the FDA is going to approve Gimoti Nasal Spray or not. Either way it will be time to move on. I do hope Evoke Pharma is planning on marketing Gimoti themselves or sale it for $65 to $70 a share, because it is up to a $4 billion dollar market to treat Gastroparesis disease in pill form of Metoclopramide or expense injection form of Metoclopramide and only those 2 are sharing up to the $4 billion dollar prescription market to treat the disease.
The Pill form of Metoclopramide takes hours sometimes a day to work to relief the symptoms cause by gastroparesis disease. The injection form of Metoclopramide is very costly and it is injected into the patient's muscles and that take up to 1 hour to work. Evoke Pharma inc form of Metoclopramide administrative by use of a nasal spray form works squirted into the nasal cavity and works in just minutes to relief symptoms cause by the gastroparesis disease.
When FDA approve Gimoti nasal spray, the professional medical field in the medical joural expect for Gimoti nasal spray form of metoclopramide to dominate the prescription market to treat Diabetic Gastroparesis disease in women because of it safety, fast action to relief symptoms, and it effectiveness.
Kartoon Channel will fit right in with Cartoon network, Nicktoon, for toddlers and preschoolers. Kids can down load Genius Brands International on their ipads and other mobile devices. Starting Monday June 15th. Parents and Kids will be able to watch Kartoon Channel on their television and down load it on their mobile devices and ipads.
Cartoon Network, Nickelodeon, Nicktoon, and Disney channels all are hit channel for kids of all ages. Genius Brands International, Inc will fit right in with these network channels. Shareholders will be looking at mega success, when Kartoon Channel becomes a major hit kids tv and mobile device hit.
you're right let daytraders have their fun flipping. I'm waiting for Monday and the rest of the month to see how it goes when Genius Brands International, inc Launches its own Kartoon Channel with over 100 million television viewers and over 200 million mobile devices. The will showing more than 4000 friendly feature presentations. This net work will get bought out very soon if all goes well.
Its power hour and Seanergy Maritime Holdings Corp. (SHIP) STILL selling shares to the market. Doing nothing, but destroying its shareholders investments.
and Seanergy Maritime Holdings Corp held us back today. I don't understand, but I will after today. Its doesn't make sense for a company like Seanergy Maritime Holdings to completely try and destroy their shareholders, just because they don't know how to make a shipping company successful with out dilution, selling shares.
come on Seanergy Maritime Holdings Corp. Let the stock run. Stop selling so many shares keeping the share price down.
Come on .30 so I can at least get half of my money back. The Ocean shipping industry is now doing good since the Coronavirus pandemic is behind all the major trading countries.
Would love to see the share price reflect the volume traded today. Over 356 million shares traded today. "SHIP" didn't even break .30 cents. I still believe the company will let it run, once they get their funds.
Why is it trading so low, with over 350 million shares traded today, and the share price is sitting at .20 cents.
Only 2 weeks to go before June 19th approval of Gimoti nasal spray form of metoclopramide to treat diabetic gastroparesis disease. Gimoti the 1st advance treatment to relieve the symptoms fast quick effective, and safe in over 40 years. in the form of a metoclopramide nasal spray by Evoke Pharma inc. a $2 to $4 billion dollar annual cost to treat the disease with only 1 pill form of metoclopramide to help to treat the symptoms. In pill forms Metoclopramide takes hours to work to release the symptoms. Gimoti nasal spray form of metoclopramide works in minutes when squirt into the nasal cavity it goes straight to the bloodstream and start relieving painful and bloated symptoms in minutes. Gimoti nasal spray form of metoclopramide to help to relief the symptoms of food and medicine trapped in the stomach for hours and sometime for days.
I've a bunch of Gnus. I also will sell all just to buy more of $EVOK. I held that stock from .23 this year. I have made so much with GNUS, but I will sell it sometime next week alone with F just to take a chance to reap financial prosperity with "EVOK". I believe this time Evoke Pharma inc stock EVOK is a go getting a FDA approval, and I'm glad I'am in it to win it.